Webinar on-demand
Why you should consider Göttingen Minipigs as your large animal model
Watch an informative
hour about the benefits of Göttingen Minipigs in translational research
Download this event to learn more about the use of minipigs in biomedical research
In this live webinar, we will present and discuss why you should consider Göttingen Minipigs as your large animal model
“We strongly believe that a more extensive use of Göttingen Minipigs, possessing huge anatomical, physiological, and biochemical similarities to humans will increase the translational value of the preclinical studies,” says Lars Friis Mikkelsen, CEO at Ellegaard Göttingen Minipigs.
How the use of Göttingen Minipigs will add value to your translational research and support the understanding of human diseases
Göttingen Minipigs are more and more used as a large animal model – and not only within traditional areas like dermatology and metabolic diseases, but also within immunology and the development of large molecule-based drugs.
Watch our webinar with international experts, sharing their knowledge and most important findings from years of experience.
Host and speakers
-
Host, Lars Friis Mikkelsen
- CEO, Ellegaard Göttingen Minipigs
-
Speaker, Susanne Mohr
- Senior Toxicology Project Lead, F. Hoffmann-La Roche, Basel, Switzerland
-
Speaker, Steven Van Cruchten
- Professor, Comparative Perinatal Development, University of Antwerp, Belgium
-
Speaker, Edward Marsden
- Associate Director, ERT, DART & Juvenile Toxicology, Charles River Laboratories, Lyon, France